A detailed history of Full Sail Capital, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Full Sail Capital, LLC holds 1,548 shares of LLY stock, worth $1.19 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
1,548
Previous 2,752 43.75%
Holding current value
$1.19 Million
Previous $2.49 Million 44.96%
% of portfolio
0.09%
Previous 0.17%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$772.14 - $960.02 $929,656 - $1.16 Million
-1,204 Reduced 43.75%
1,548 $1.37 Million
Q2 2024

Aug 14, 2024

SELL
$724.87 - $909.04 $2,899 - $3,636
-4 Reduced 0.15%
2,752 $2.49 Million
Q1 2024

May 14, 2024

SELL
$592.2 - $792.28 $17,766 - $23,768
-30 Reduced 1.08%
2,756 $2.14 Million
Q4 2023

Feb 13, 2024

SELL
$525.19 - $619.13 $112,915 - $133,112
-215 Reduced 7.16%
2,786 $1.62 Million
Q3 2023

Nov 13, 2023

SELL
$434.7 - $599.3 $19,561 - $26,968
-45 Reduced 1.48%
3,001 $1.61 Million
Q2 2023

Aug 14, 2023

SELL
$350.74 - $468.98 $90,140 - $120,527
-257 Reduced 7.78%
3,046 $1.43 Million
Q1 2023

May 04, 2023

BUY
$310.63 - $364.82 $242,291 - $284,559
780 Added 30.92%
3,303 $1.13 Million
Q4 2022

Feb 06, 2023

BUY
$321.55 - $374.67 $580,719 - $676,654
1,806 Added 251.88%
2,523 $923,000
Q3 2022

Nov 09, 2022

SELL
$296.48 - $337.87 $5,929 - $6,757
-20 Reduced 2.71%
717 $232,000
Q1 2022

May 12, 2022

BUY
$234.69 - $291.66 $172,966 - $214,953
737 New
737 $211,000
Q4 2021

Feb 14, 2022

SELL
$224.85 - $279.04 $390,564 - $484,692
-1,737 Closed
0 $0
Q2 2021

Aug 12, 2021

SELL
$180.55 - $233.54 $45,498 - $58,852
-252 Reduced 12.67%
1,737 $398,000
Q1 2021

May 12, 2021

BUY
$164.32 - $212.72 $47,488 - $61,476
289 Added 17.0%
1,989 $364,000
Q1 2020

May 15, 2020

SELL
$119.05 - $147.35 $9,881 - $12,230
-83 Reduced 4.66%
1,700 $261,000
Q1 2019

May 16, 2019

BUY
$111.31 - $131.02 $198,465 - $233,608
1,783 New
1,783 $231,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Full Sail Capital, LLC Portfolio

Follow Full Sail Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Full Sail Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Full Sail Capital, LLC with notifications on news.